Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory AML

Clinical trial NCT01191801 · COMPLETED

Trial details

NCT number: NCT01191801
Sponsor: Sunesis Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 2010-12-17
Primary completion: 2014-09-26
Enrollment: 711

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.